Biochemical Liver Function Test Parameter Levels in Relation to Treatment Response in Liver Metastatic Colorectal Patients Treated With FOLFOX4 With or Without Bevacizumab

Srpski Arhiv Za Celokupno Lekarstvo - Serbia
doi 10.2298/sarh1612615d
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

National Library of Serbia

Related search

Perioperative Chemotherapy With or Without Bevacizumab in Patients With Metastatic Colorectal Cancer Undergoing Liver Resection

Clinical Colorectal Cancer
OncologyGastroenterology
2013English

Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer

JAMA Surgery
Surgery
2018English

Post-Treatment Surveillance of Patients With Colorectal Cancer With Surgically Treated Liver Metastases

Surgery
Surgery
2013English

Hypertension and Overall Survival in Metastatic Colorectal Cancer Patients Treated With Bevacizumab-Containing Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
2011English

Biochemical Liver Function After Partial Hepatic Resection With or Without Partial Hepatic Vascular Exclusion

Acta Cirurgica Brasileira
Surgery
2011English

Cediranib With mFOLFOX6 vs Bevacizumab With mFOLFOX6 in Previously Treated Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2013English

Perioperative Chemotherapy With Bevacizumab and Liver Resection for Colorectal Cancer Liver Metastasis

HPB
HepatologyGastroenterology
2010English

Impact of Bevacizumab on Parenchymal Damage and Functional Recovery of the Liver in Patients With Colorectal Liver Metastases

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Measurement of Response to Treatment in Colorectal Liver Metastases

British Journal of Cancer
Cancer ResearchOncology
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy